Although NSCLC, papillary thyroid cancer (PTC), and medullary thyroid cancer (MTC) collectively account for the majority of RET-altered cancers, a plurality of additional tumor histologies also harbor RET alterations. This evidence concerns the gene RET and medullary thyroid gland carcinoma.